I. Vodkin

发表

MRI Assessment of Treatment Response in HIV‐associated NAFLD: A Randomized Trial of a Stearoyl‐Coenzyme‐A‐Desaturase‐1 Inhibitor (ARRIVE Trial)

C. Sirlin, O. D. Leinhard, R. Loomba, 2019, Hepatology.

Clinical, biochemical and histological differences between HIV‐associated NAFLD and primary NAFLD: a case–control study

M. Valasek, R. Loomba, R. Bettencourt, 2015, Alimentary pharmacology & therapeutics.

Increased Risk of Death, in the Hospital and Outside the Intensive Care Unit, for Patients With Cirrhosis After Cardiac Arrest

D. Brenner, T. Savides, R. Loomba, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Editorial: NAFLD in HIV infection – call for action. Authors' reply

R. Loomba, I. Vodkin, 2015, Alimentary pharmacology & therapeutics.

Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis

N. Schork, D. Brenner, C. Sirlin, 2017, The Journal of clinical investigation.

Letter: HIV‐associated NAFLD – more questions than answers? Authors’ reply

R. Loomba, I. Vodkin, I. Vodkin, 2015, Alimentary pharmacology & therapeutics.

Alcohol use is prevalent among adults with the fontan circulation but does not correlate with liver disease

R. Reeves, H. El-Said, L. Alshawabkeh, 2022, International Journal of Cardiology Congenital Heart Disease.

Extended Criteria Donors in Liver Transplantation.

A. Kuo, I. Vodkin, 2017, Clinics in liver disease.

Management of Hepatitis B virus infection during pregnancy.

H. Patton, I. Vodkin, 2014, Minerva gastroenterologica e dietologica.

Evaluation of Fontan liver disease: Correlation of transjugular liver biopsy with magnetic resonance and hemodynamics.

J. Dwek, J. Moore, J. Perry, 2019, Congenital heart disease.

Transjugular liver biopsy for Fontan associated liver disease surveillance: Technique, outcomes and hemodynamic correlation.

J. Moore, J. Perry, R. Towbin, 2020, International journal of cardiology.

Pre- and Post-Portosystemic Shunt Placement Metabolomics Reveal Molecular Signatures for the Development of Hepatic Encephalopathy

A. C. Dantas Machado, A. Zarrinpar, D. Petráš, 2023, medRxiv.

Exercise MRI highlights heterogeneity in cardiovascular mechanics among patients with Fontan circulation: proposed protocol for routine evaluation

A. Marsden, S. Hegde, Weiguang Yang, 2020, Journal of thoracic disease.

Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy

Y. Kono, M. Hosseini, V. Ajmera, 2021, Clinical Journal of Gastroenterology.

Eliciting Patient Preferences for Hepatocellular Carcinoma Screening: A Choice-Based Conjoint Analysis.

Robert M. Marks, Kathryn J Fowler, B. Taouli, 2022, Journal of the American College of Radiology : JACR.

Secondary peritonitis in a patient with cirrhosis involving Hyphopichia burtonii, an emerging fungal pathogen

B. Kamdar, S. Abeles, I. Vodkin, 2023, IDCases.

Successful optimization of antiretroviral regimens in treatment‐experienced people living with HIV undergoing liver transplantation

Stephen A. Rawlings, C. Logan, S. Mehta, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

The effects of Share 35 on the cost of liver transplantation

K. Mekeel, A. Hemming, J. Halldorson, 2017, Clinical transplantation.

Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry

A. C. Dantas Machado, A. Zarrinpar, D. Petráš, 2023, Nature communications.